Trastuzumab ELISA (mAb-based)
Enzyme immunoassay for the quantitative determination of free Trastuzumab (Herceptin®, Herclon®) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Trastuzumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Reference: IG-AB105
Barcode: 8682754930165
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-AB105 730.94 KB
Material Safety Data Sheet (MSDS) IG-AB105 268.23 KB
Herceptin® and Herclon® are trademarks Genentech Inc.
The Kit at a glance:
| Required Volume (µL) | 10 |
| Incubation Time (min) | 100 |
| Sample | Serum or Plasma |
| Package Size | 96 Tests |
| Standard Range (ng/mL, 10x) | 0-2000 |
| Detection Limit (ng/mL) | 5 |
| Spike Recovery (%) | >95 |
| Shelf Life (years) | 2 |
Standard Curve:
